Services

Launch capital and operating strategy

A six- to eight-week, executive-led engagement that answers one question for a company preparing for its first independent U.S. launch: how much capital will you need to launch, and what organization should you build?

Ideal client profile

Approval

18 to 30 months away, 24 ideal

Employees

About 10 to 75

Commercial build

Limited so far

Ahead

Financing, budget cycle, or board decision

Built for a company about two years from approval

The engagement is for a U.S. biotech that has already decided to commercialize independently and has a decision on launch investment coming up. Starting about 24 months before approval leaves time to sequence hires and vendor commitments, and to put the capital plan in front of the board before spending starts.

The questions it answers

  • How much capital does commercialization preparation need?
  • How should the company be structured for its first launch?
  • Which leadership and operating roles should be hired, and when?
  • What should be outsourced?
  • What technology infrastructure is needed?
  • Can AI and agentic workflows improve operating capacity or capital efficiency?
  • What happens if approval or launch is delayed?
  • How should the commercialization investment plan be presented to the board and investors?

Five phases over eight weeks

Wk 1

Wk 2

Wk 3

Wk 4

Wk 5

Wk 6

Wk 7

Wk 8

Wk 1

Diagnose

Leadership interviews, current organization, budgets, launch milestones

Baseline assessment and assumptions

Management approves assumptions

Wk 2

Set readiness requirements

Capability inventory, dependencies, readiness gates

Commercial-readiness requirements

Management approves assumptions

Wk 3–4

Design operating alternatives

Organization, FTEs, hiring, vendors, AI and technology

Three operating-model alternatives

Management approves assumptions

Wk 5–6

Model the investment

Compensation, quarterly cash, vendors, technology, sensitivity scenarios

Editable financial model

Management approves assumptions

Wk 7–8

Recommend and roadmap

Evaluate alternatives, facilitate executive decisions, implementation plan

Board-ready recommendations and roadmap

Management approves assumptions at a checkpoint between each phase.

Six weeks is possible when inputs are readily available.

What management receives

Pre-launch capital model

An editable workbook with role-level compensation, hiring dates, outsourced services, technology, AI investment, quarterly expense, and scenario sensitivities.

Commercial organizational design

The target organization, with each activity assigned to an employee, a vendor, software, an agent, or a shared service.

Operating-model alternatives

Traditional, AI-Enhanced, and AI-First designs built on the same assumptions.

Technology and vendor roadmap

The quarterly sequence of systems, vendor commitments, and AI capabilities through launch.

Launch-readiness assessment

A commercial-readiness matrix and milestone roadmap covering capabilities, dependencies, systems, vendors, and procedures.

Executive recommendations

A recommended operating model, decision gates, and a presentation for the board.

What management provides

A short list of inputs, most of which already exist in board materials and budgets.

  • Product and approval timing
  • Commercial strategy
  • Current organization chart
  • Cash runway and budgets
  • Vendors and existing commitments
  • Current technology
  • Milestones
  • Existing plans and board materials

Data boundary

Aggregate business data only. RF Consulting does not need or accept identifiable patient information.

Scope

The engagement covers commercial readiness and organizational investment. It can incorporate management’s clinical, regulatory, and manufacturing budgets into a consolidated capital view but does not build or validate them.

Separate engagements

  • Executive recruiting
  • Vendor contracting
  • CRM or ERP implementation
  • Production AI engineering
  • Full revenue or gross-to-net forecasting

Preparing for a financing, a budget cycle, or a board decision on launch investment?

Send a short note on where the program stands. Rommel replies personally.